TP53 and ovarian serous adenocarcinoma: We aimed to evaluate the clinical relevance of p53 (Δ133p53, Δ40p53, and FLp53) and p73 isoforms (TAp73 and ΔTAp73) that modulate the function of p53 in patients with advanced serous ovarian cancer.